1. Home
  2. DAVE vs RGEN Comparison

DAVE vs RGEN Comparison

Compare DAVE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dave Inc.

DAVE

Dave Inc.

N/A

Current Price

$354.72

Market Cap

5.6B

Sector

Technology

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$181.13

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DAVE
RGEN
Founded
2017
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.6B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
DAVE
RGEN
Price
$354.72
$181.13
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$312.75
$167.67
AVG Volume (30 Days)
415.4K
1.2M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
222.91
286.96
EPS
4.60
0.24
Revenue
$554,182,000.00
$141,236,000.00
Revenue This Year
$26.28
$14.30
Revenue Next Year
$17.38
$14.52
P/E Ratio
$72.83
$751.21
Revenue Growth
59.67
35.10
52 Week Low
$152.21
$100.99
52 Week High
$458.25
$188.73

Technical Indicators

Market Signals
Indicator
DAVE
RGEN
Relative Strength Index (RSI) 48.94 76.48
Support Level $225.43 $156.65
Resistance Level $448.24 N/A
Average True Range (ATR) 22.39 6.79
MACD -1.78 1.81
Stochastic Oscillator 38.14 84.69

Price Performance

Historical Comparison
DAVE
RGEN

About DAVE Dave Inc.

Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: